Retraction

Pharmacogenomic strategies provide a rational approach to the treatment of cisplatin-resistant patients with advanced cancer

Retraction Details

Citations (92)

92
Total Citations
31
Post-Retraction
(33.7%)
55
Pre-Retraction
0
Same Day
Post-Retraction Citation Analysis
1 Within 30 days
11 Within 1 year
15 After 2+ years
3979 Days since retraction (latest)
Paper citing A genomic approach to identify molecular pathways ...
Unknown Authors
Unknown Journal
Published: Unknown
Paper citing Pharmacogenomic strategies provide a rational appr...
Unknown Authors
Unknown Journal
Published: Unknown
Paper citing Pharmacogenomic strategies provide a rational appr...
Unknown Authors
Unknown Journal
Published: Unknown
Paper citing A Genomic Strategy to Refine Prognosis in Early-St...
Unknown Authors
Unknown Journal
Published: Unknown
Paper citing Pharmacogenomic strategies provide a rational appr...
Unknown Authors
Unknown Journal
Published: Unknown
Paper citing Pharmacogenomic strategies provide a rational appr...
Unknown Authors
Unknown Journal
Published: Unknown
Paper citing Pharmacogenomic strategies provide a rational appr...
Unknown Authors
Unknown Journal
Published: Nov 2021
3979 days after retraction
Paper citing Pharmacogenomic strategies provide a rational appr...
Unknown Authors
Unknown Journal
Published: Jul 2021
3856 days after retraction
Paper citing Pharmacogenomic strategies provide a rational appr...
Unknown Authors
Unknown Journal
Published: Sep 2019
3187 days after retraction
Paper citing Pharmacogenomic strategies provide a rational appr...
Unknown Authors
Unknown Journal
Published: Jan 2019
2961 days after retraction
Paper citing Pharmacogenomic strategies provide a rational appr...
Unknown Authors
Unknown Journal
Published: May 2018
2699 days after retraction
Paper citing Genomic signatures to guide the use of chemotherap...
Unknown Authors
Unknown Journal
Published: Jun 2017
2379 days after retraction
Paper citing Pharmacogenomic strategies provide a rational appr...
Unknown Authors
Unknown Journal
Published: Sep 2016
2093 days after retraction
Paper citing Selective killing of cancer cells by a small molec...
Unknown Authors
Unknown Journal
Published: Sep 2016
2092 days after retraction
Paper citing A Genomic Strategy to Refine Prognosis in Early-St...
Unknown Authors
Unknown Journal
Published: Feb 2015
1514 days after retraction
Paper citing Pharmacogenomic strategies provide a rational appr...
Unknown Authors
Unknown Journal
Published: Jul 2014
1328 days after retraction
Paper citing A Genomic Strategy to Refine Prognosis in Early-St...
Unknown Authors
Unknown Journal
Published: Nov 2013
1064 days after retraction
Paper citing Genomic signatures to guide the use of chemotherap...
Unknown Authors
Unknown Journal
Published: Aug 2013
984 days after retraction
Paper citing Pharmacogenomic strategies provide a rational appr...
Unknown Authors
Unknown Journal
Published: May 2013
885 days after retraction
Paper citing Pharmacogenomic strategies provide a rational appr...
Unknown Authors
Unknown Journal
Published: Apr 2013
843 days after retraction
Paper citing Pharmacogenomic strategies provide a rational appr...
Unknown Authors
Unknown Journal
Published: Feb 2013
784 days after retraction
Paper citing Genomic signatures to guide the use of chemotherap...
Unknown Authors
Unknown Journal
Published: Dec 2012
722 days after retraction
Paper citing A Genomic Strategy to Refine Prognosis in Early-St...
Unknown Authors
Unknown Journal
Published: Jun 2012
564 days after retraction
Paper citing An integrated genomic-based approach to individual...
Unknown Authors
Unknown Journal
Published: May 2012
517 days after retraction
Paper citing Genomic signatures to guide the use of chemotherap...
Unknown Authors
Unknown Journal
Published: Mar 2012
462 days after retraction
Paper citing Genomic signatures to guide the use of chemotherap...
Unknown Authors
Unknown Journal
Published: Mar 2012
447 days after retraction
Paper citing Pharmacogenomic strategies provide a rational appr...
Unknown Authors
Unknown Journal
Published: Sep 2011
265 days after retraction
Paper citing Pharmacogenomic strategies provide a rational appr...
Unknown Authors
Unknown Journal
Published: Sep 2011
265 days after retraction
Paper citing A Genomic Strategy to Refine Prognosis in Early-St...
Unknown Authors
Unknown Journal
Published: Aug 2011
236 days after retraction
Paper citing Pharmacogenomic strategies provide a rational appr...
Unknown Authors
Unknown Journal
Published: Aug 2011
234 days after retraction
Paper citing Pharmacogenomic strategies provide a rational appr...
Unknown Authors
Unknown Journal
Published: Jul 2011
203 days after retraction
Paper citing A Genomic Strategy to Refine Prognosis in Early-St...
Unknown Authors
Unknown Journal
Published: Jun 2011
183 days after retraction
Paper citing A Genomic Strategy to Refine Prognosis in Early-St...
Unknown Authors
Unknown Journal
Published: May 2011
142 days after retraction
Paper citing An integrated genomic-based approach to individual...
Unknown Authors
Unknown Journal
Published: Mar 2011
101 days after retraction
Paper citing A Genomic Strategy to Refine Prognosis in Early-St...
Unknown Authors
Unknown Journal
Published: Jan 2011
48 days after retraction
Paper citing Genomic signatures to guide the use of chemotherap...
Unknown Authors
Unknown Journal
Published: Jan 2011
32 days after retraction
Paper citing Genomic signatures to guide the use of chemotherap...
Unknown Authors
Unknown Journal
Published: Dec 2010
5 days after retraction
Paper citing Characterizing the Clinical Relevance of an Embryo...
Unknown Authors
Unknown Journal
Published: Oct 2010
70 days before retraction
Paper citing Phase II study of the anti-insulin-like growth fac...
Unknown Authors
Unknown Journal
Published: Sep 2010
100 days before retraction
Paper citing Genomic signatures to guide the use of chemotherap...
Unknown Authors
Unknown Journal
Published: Sep 2010
100 days before retraction
Paper citing Pharmacogenomic strategies provide a rational appr...
Unknown Authors
Unknown Journal
Published: Aug 2010
131 days before retraction
Paper citing Pharmacogenomic strategies provide a rational appr...
Unknown Authors
Unknown Journal
Published: Jun 2010
168 days before retraction
Paper citing A Genomic Strategy to Refine Prognosis in Early-St...
Unknown Authors
Unknown Journal
Published: Apr 2010
251 days before retraction
Paper citing Pharmacogenomic strategies provide a rational appr...
Unknown Authors
Unknown Journal
Published: Mar 2010
255 days before retraction
Paper citing Pharmacogenomic strategies provide a rational appr...
Unknown Authors
Unknown Journal
Published: Mar 2010
270 days before retraction
Paper citing Pharmacogenomic strategies provide a rational appr...
Unknown Authors
Unknown Journal
Published: Mar 2010
284 days before retraction
Paper citing An integrated genomic-based approach to individual...
Unknown Authors
Unknown Journal
Published: Jan 2010
329 days before retraction
Paper citing An integrated genomic-based approach to individual...
Unknown Authors
Unknown Journal
Published: Jan 2010
330 days before retraction
Paper citing A genomic approach to identify molecular pathways ...
Unknown Authors
Unknown Journal
Published: Dec 2009
374 days before retraction
Paper citing Pharmacogenomic strategies provide a rational appr...
Unknown Authors
Unknown Journal
Published: Dec 2009
374 days before retraction
Related Records

This article has multiple records in the database due to different notices:

Record #16683
Jun 01, 2010
Correction
Quick Stats
Total Citations: 92
Years Since Retraction: 14.9 years
Open Access: Yes
Last Checked: Never
Related Papers
Combination Anti-CTLA-4 and Anti-RANKL in Metastatic Melano…
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology • 74 citations
Resistance to CDK4/6 inhibitors (CDK4/6i): The clinical use…
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology • 0 citations
Usefulness of assessment of circulating tumor DNA(ctDNA) of…
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology • 2 citations
Usefulness of assessment of circulating tumor DNA(ctDNA) of…
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology • 2 citations
Resistance to CDK4/6 inhibitors (CDK4/6i): The clinical use…
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology • 0 citations